AIM – A Decade of Achievement Hardman & Co Monthly

In the November edition of the Hardman Monthly Newsletter, Nigel Hawkins assesses the achievements of AIM – and how it has thrived, despite a challenging financial environment, in recent years.

► AIM, which was founded in 1995, now hosts 959 stocks, currently worth over £100 billion.

► Since its founding, over £100 billion has been raised by AIM-quoted stocks – with 2006 and 2007 being its best years.

► The AIM Index has risen by 31% over the last year and by over 60% during the last five years. Impressive.

► AIM now hosts eleven companies with valuations of over £1 billion each, led by top on-line clothing retailer ASOS, currently worth c£5 billion.

► Liquidity on AIM has improved remarkably in recent years – Read Keith Hiscock’s article: Liquidity – little understood, even before MIFID II.

Share on:

Written by: Giles Arbor

Hardman & Co

Latest Company News

Ilika plc Advances Solid-State Batteries With 10Ah Goliath Breakthrough (Video)

December 12, 2025

Ilika plc has shipped its 10Ah Goliath solid-state battery prototypes, marking a major scale-up from earlier designs. CEO Graeme Purdy outlines how higher-energy materials and an automated pilot line delivered a 93% yield, signalling readiness for larger-scale manufacturing.

Harbour Energy to acquire Waldorf subsidiaries in $170m deal, boosting UK production

December 12, 2025

Harbour Energy has agreed to acquire most subsidiaries of Waldorf Energy Partners and Waldorf Production for $170 million, a move expected to add 20 kboepd of oil weighted production and 35 mmboe of 2P reserves.

TwentyFour Income Fund reports positive month as ABS and CLO issuance hits post-crisis highs

December 12, 2025

TwentyFour Income Fund noted improved market sentiment in November, supported by progress in Ukraine peace discussions and a stable UK Budget response.

GSK RSV vaccine recommended for wider adult use, CHMP backs expansion

December 12, 2025

GSK has announced that the EMA’s CHMP has recommended broadening the indication of its adjuvanted RSV vaccine to adults aged 18 and over, with a final decision expected in February 2026.

UK equities regain investor interest as valuation opportunities widen

December 12, 2025

Fidelity Special Values manager Alex Wright says UK equities have seen renewed interest as valuations remain attractive compared with global peers. The trust continues to follow a contrarian approach, focusing on undervalued mid and small cap companies and aiming to identify positive change not yet reflected in share prices.

Global Opportunities Trust reaffirms successful value and absolute-return strategy (LON: GOT)

December 12, 2025

As at the end of October 2025, Global Opportunities Trust continued to apply its value focused strategy across global markets, holding a blend of equities, private market investments and significant liquidity positions.